I would not be surprised at all if a partnership has already been discussed and soon everyone will know. We eventually could have many partnerships. It all depends how things progress. By looking for a Director of Clinical Trials, I believe TGD is going to bombard the market with several more trials in the coming year! He is on a roll now, and not stopping for anyone!!!!!!!!
Tred, one has to wonder if part of the negotiations with FDA were directed towards an universal approval of 2-73 for all CNS diseases if 2-73 were successful in each of the three trials, based on the premise that all CNS diseases have the same cellular deficiencies and 2-73 alleviates/rectifies those deficiencies.
News 
Market Data 
Discover 
